Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired Hemophilia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Traditional Therapy
1.2.3 Advanced Therapy
1.3 Market by Application
1.3.1 Global Acquired Hemophilia Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acquired Hemophilia Treatment Market Perspective (2018-2033)
2.2 Acquired Hemophilia Treatment Growth Trends by Region
2.2.1 Global Acquired Hemophilia Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acquired Hemophilia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Acquired Hemophilia Treatment Forecasted Market Size by Region (2024-2033)
2.3 Acquired Hemophilia Treatment Market Dynamics
2.3.1 Acquired Hemophilia Treatment Industry Trends
2.3.2 Acquired Hemophilia Treatment Market Drivers
2.3.3 Acquired Hemophilia Treatment Market Challenges
2.3.4 Acquired Hemophilia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acquired Hemophilia Treatment Players by Revenue
3.1.1 Global Top Acquired Hemophilia Treatment Players by Revenue (2018-2023)
3.1.2 Global Acquired Hemophilia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Acquired Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acquired Hemophilia Treatment Revenue
3.4 Global Acquired Hemophilia Treatment Market Concentration Ratio
3.4.1 Global Acquired Hemophilia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired Hemophilia Treatment Revenue in 2022
3.5 Acquired Hemophilia Treatment Key Players Head office and Area Served
3.6 Key Players Acquired Hemophilia Treatment Product Solution and Service
3.7 Date of Enter into Acquired Hemophilia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acquired Hemophilia Treatment Breakdown Data by Type
4.1 Global Acquired Hemophilia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2024-2033)
5 Acquired Hemophilia Treatment Breakdown Data by Application
5.1 Global Acquired Hemophilia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acquired Hemophilia Treatment Market Size (2018-2033)
6.2 North America Acquired Hemophilia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acquired Hemophilia Treatment Market Size by Country (2018-2023)
6.4 North America Acquired Hemophilia Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acquired Hemophilia Treatment Market Size (2018-2033)
7.2 Europe Acquired Hemophilia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acquired Hemophilia Treatment Market Size by Country (2018-2023)
7.4 Europe Acquired Hemophilia Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acquired Hemophilia Treatment Market Size (2018-2033)
8.2 Asia-Pacific Acquired Hemophilia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acquired Hemophilia Treatment Market Size (2018-2033)
9.2 Latin America Acquired Hemophilia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acquired Hemophilia Treatment Market Size by Country (2018-2023)
9.4 Latin America Acquired Hemophilia Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acquired Hemophilia Treatment Market Size (2018-2033)
10.2 Middle East & Africa Acquired Hemophilia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxalta, Inc.
11.1.1 Baxalta, Inc. Company Detail
11.1.2 Baxalta, Inc. Business Overview
11.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Introduction
11.1.4 Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2018-2023)
11.1.5 Baxalta, Inc. Recent Development
11.2 Baxter Healthcare Corporation
11.2.1 Baxter Healthcare Corporation Company Detail
11.2.2 Baxter Healthcare Corporation Business Overview
11.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Introduction
11.2.4 Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2018-2023)
11.2.5 Baxter Healthcare Corporation Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Genentech, Inc.
11.4.1 Genentech, Inc. Company Detail
11.4.2 Genentech, Inc. Business Overview
11.4.3 Genentech, Inc. Acquired Hemophilia Treatment Introduction
11.4.4 Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2018-2023)
11.4.5 Genentech, Inc. Recent Development
11.5 Novo Nordisk A/S
11.5.1 Novo Nordisk A/S Company Detail
11.5.2 Novo Nordisk A/S Business Overview
11.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Introduction
11.5.4 Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2018-2023)
11.5.5 Novo Nordisk A/S Recent Development
11.6 Ferring B.V.
11.6.1 Ferring B.V. Company Detail
11.6.2 Ferring B.V. Business Overview
11.6.3 Ferring B.V. Acquired Hemophilia Treatment Introduction
11.6.4 Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2018-2023)
11.6.5 Ferring B.V. Recent Development
11.7 Sanofi SA
11.7.1 Sanofi SA Company Detail
11.7.2 Sanofi SA Business Overview
11.7.3 Sanofi SA Acquired Hemophilia Treatment Introduction
11.7.4 Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2018-2023)
11.7.5 Sanofi SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acquired Hemophilia Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Traditional Therapy
Table 3. Key Players of Advanced Therapy
Table 4. Global Acquired Hemophilia Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Acquired Hemophilia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Acquired Hemophilia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Acquired Hemophilia Treatment Market Share by Region (2018-2023)
Table 8. Global Acquired Hemophilia Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Acquired Hemophilia Treatment Market Share by Region (2024-2033)
Table 10. Acquired Hemophilia Treatment Market Trends
Table 11. Acquired Hemophilia Treatment Market Drivers
Table 12. Acquired Hemophilia Treatment Market Challenges
Table 13. Acquired Hemophilia Treatment Market Restraints
Table 14. Global Acquired Hemophilia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Acquired Hemophilia Treatment Market Share by Players (2018-2023)
Table 16. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Hemophilia Treatment as of 2022)
Table 17. Ranking of Global Top Acquired Hemophilia Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Acquired Hemophilia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acquired Hemophilia Treatment Product Solution and Service
Table 21. Date of Enter into Acquired Hemophilia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acquired Hemophilia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Acquired Hemophilia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Acquired Hemophilia Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Acquired Hemophilia Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Acquired Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Acquired Hemophilia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Acquired Hemophilia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Acquired Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Acquired Hemophilia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Acquired Hemophilia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Acquired Hemophilia Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Acquired Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Acquired Hemophilia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Acquired Hemophilia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Acquired Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Baxalta, Inc. Company Detail
Table 47. Baxalta, Inc. Business Overview
Table 48. Baxalta, Inc. Acquired Hemophilia Treatment Product
Table 49. Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 50. Baxalta, Inc. Recent Development
Table 51. Baxter Healthcare Corporation Company Detail
Table 52. Baxter Healthcare Corporation Business Overview
Table 53. Baxter Healthcare Corporation Acquired Hemophilia Treatment Product
Table 54. Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 55. Baxter Healthcare Corporation Recent Development
Table 56. Bristol-Myers Squibb Company Detail
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Acquired Hemophilia Treatment Product
Table 59. Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. Genentech, Inc. Company Detail
Table 62. Genentech, Inc. Business Overview
Table 63. Genentech, Inc. Acquired Hemophilia Treatment Product
Table 64. Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 65. Genentech, Inc. Recent Development
Table 66. Novo Nordisk A/S Company Detail
Table 67. Novo Nordisk A/S Business Overview
Table 68. Novo Nordisk A/S Acquired Hemophilia Treatment Product
Table 69. Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 70. Novo Nordisk A/S Recent Development
Table 71. Ferring B.V. Company Detail
Table 72. Ferring B.V. Business Overview
Table 73. Ferring B.V. Acquired Hemophilia Treatment Product
Table 74. Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 75. Ferring B.V. Recent Development
Table 76. Sanofi SA Company Detail
Table 77. Sanofi SA Business Overview
Table 78. Sanofi SA Acquired Hemophilia Treatment Product
Table 79. Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2018-2023) & (US$ Million)
Table 80. Sanofi SA Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired Hemophilia Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acquired Hemophilia Treatment Market Share by Type: 2022 VS 2033
Figure 3. Traditional Therapy Features
Figure 4. Advanced Therapy Features
Figure 5. Global Acquired Hemophilia Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Acquired Hemophilia Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Acquired Hemophilia Treatment Report Years Considered
Figure 11. Global Acquired Hemophilia Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Acquired Hemophilia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Acquired Hemophilia Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Acquired Hemophilia Treatment Market Share by Players in 2022
Figure 15. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Hemophilia Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Acquired Hemophilia Treatment Revenue in 2022
Figure 17. North America Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Acquired Hemophilia Treatment Market Share by Country (2018-2033)
Figure 19. United States Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Acquired Hemophilia Treatment Market Share by Country (2018-2033)
Figure 23. Germany Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Acquired Hemophilia Treatment Market Share by Region (2018-2033)
Figure 31. China Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Acquired Hemophilia Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Acquired Hemophilia Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Acquired Hemophilia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Baxalta, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2018-2023)
Figure 46. Baxter Healthcare Corporation Revenue Growth Rate in Acquired Hemophilia Treatment Business (2018-2023)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Acquired Hemophilia Treatment Business (2018-2023)
Figure 48. Genentech, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2018-2023)
Figure 49. Novo Nordisk A/S Revenue Growth Rate in Acquired Hemophilia Treatment Business (2018-2023)
Figure 50. Ferring B.V. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2018-2023)
Figure 51. Sanofi SA Revenue Growth Rate in Acquired Hemophilia Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed